Unicycive Therapeutics’s (UNCY) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting Unicycive Therapeutics is a Sell.
Unicycive Therapeutics’s (UNCY) 20-Day exponential moving average is 3.73, while Unicycive Therapeutics’s (UNCY) share price is $3.55, making it a Sell.
Unicycive Therapeutics’s (UNCY) 50-Day exponential moving average is 4.15, while Unicycive Therapeutics’s (UNCY) share price is $3.55, making it a Sell.
Unicycive Therapeutics’s (UNCY) 10-Day exponential moving average is 3.65, while Unicycive Therapeutics’s (UNCY) share price is $3.55, making it a Sell.
Unicycive Therapeutics’s (UNCY) 100-Day exponential moving average is 4.77, while Unicycive Therapeutics’s (UNCY) share price is $3.55, making it a Sell.
Unicycive Therapeutics’s (UNCY) stock price is $3.55 and Unicycive Therapeutics’s (UNCY) 50-day simple moving average is 4.19, creating a Sell signal.
Unicycive Therapeutics’s (UNCY) stock price is $3.55 and Unicycive Therapeutics’s (UNCY) 100-day simple moving average is 4.81, creating a Sell signal.
Unicycive Therapeutics’s (UNCY) stock price is $3.55 and Unicycive Therapeutics’s (UNCY) 200-day simple moving average is 5.95, creating a Sell signal.